World's Best Scientists 2026 revealed!
Philippe Morlat

Philippe Morlat

D-Index & Metrics

Microbiology

D-Index
64
Citations
14309
World Ranking
2618
National Ranking
158

Philippe Morlat publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Philippe Morlat sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 304 publications — 78th percentile

78% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Philippe Morlat D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Philippe Morlat sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 64 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Philippe Morlat is affiliated with the University of Bordeaux in France. Their research primarily focuses on medicine, with significant contributions in infectious diseases, epidemiology, virology, pharmacology, and emergency medicine.

The main topics of their research encompass:

  • HIV/AIDS Research and Interventions
  • HIV/AIDS drug development and treatment
  • HIV Research and Treatment
  • Pneumocystis jirovecii pneumonia detection and treatment
  • HIV-related health complications and treatments
  • Coffee research and impacts
  • Tryptophan and brain disorders

Morlat's recent publications span several journals and topics related to HIV, co-infections, and treatment strategies. Some recent papers include:

  • Coffee Intake and Neurocognitive Performance in HIV/HCV Coinfected Patients (ANRS CO13 HEPAVIH), 2020, Nutrients
  • Withholding Primary Pneumocystis Pneumonia Prophylaxis in Virologically Suppressed Patients With Human Immunodeficiency Virus: An Emulation of a Pragmatic Trial in COHERE, 2020, Clinical Infectious Diseases
  • No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL, 2021, Journal of the International AIDS Society
  • Atherosclerotic Cardiovascular Events in Patients Infected With Human Immunodeficiency Virus and Hepatitis C Virus, 2020, Clinical Infectious Diseases
  • Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trial, 2022, Journal of Antimicrobial Chemotherapy

Their frequent co-authors include:

  • Linda Wittkop (6 co-authored papers)
  • Christoph Stephan (5 co-authored papers)
  • Laurence Meyer (5 co-authored papers)
  • Olivier Bouchaud (5 co-authored papers)
  • David Zucman (5 co-authored papers)

Morlat's work has been published most frequently in the following venues:

  • Clinical Infectious Diseases (4 publications)
  • Journal of Antimicrobial Chemotherapy (3 publications)
  • Nutrients (1 publication)
  • Journal of the International AIDS Society (1 publication)
  • PLoS ONE (1 publication)

Best Publications

  • Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

    Colette J Smith;Lene Ryom;Rainer Weber;Philippe Morlat

  • Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.

    Caroline Charlier;Élodie Perrodeau;Alexandre Leclercq;Alexandre Leclercq;Benoît Cazenave

  • HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population.

    Charlotte Lewden;Geneviève Chene;Philippe Morlat;Francois Raffi

  • Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS

    Charlotte Lewden;Dominique Salmon;Philippe Morlat;Sibylle Bévilacqua

  • Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol

    Dominique Salmon-Ceron;Charlotte Lewden;Philippe Morlat;Sibylle Bévilacqua

  • Treatment of Toxoplasmic Encephalitis in Patients with AIDS: A Randomized Trial Comparing Pyrimethamine plus Clindamycin to Pyrimethamine plus Sulfadiazine

    B Dannemann;J A McCutchan;D Israelski;D Antoniskis

  • Changes in causes of death among adults infected by HIV between 2000 and 2005: The "Mortalité 2000 and 2005" surveys (ANRS EN19 and Mortavic).

    Charlotte Lewden;Thierry May;Eric Rosenthal;Christine Burty

  • Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study

    Lene Ryom;Amanda Mocroft;Ole Kirk;Ole Kirk;Signe W Worm

  • Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study).

    Eric Rosenthal;Marilyne Poirée;Christian Pradier;Christian Perronne

  • Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.

    Fabrice Bonnet;Fabrice Bonnet;Charlotte Lewden;Thierry May M.D.;Laurence Heripret

  • Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000.

    Philippe Morlat;Caroline Roussillon;Sandrine Henard;Dominique Salmon

  • Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy: Malignancy-Related Death in Patients with HIV

    Fabrice Bonnet;Charlotte Lewden;Thierry May;Laurence Heripret

  • CD4 Cell Count and HIV DNA Level Are Independent Predictors of Disease Progression after Primary HIV Type 1 Infection in Untreated Patients

    Cécile Goujard;Mojgan Bonarek;Laurence Meyer;Fabrice Bonnet

  • Lipodystrophy, Metabolic Disorders, and Human Immunodeficiency Virus Infection: Aquitaine Cohort, France, 1999

    Rodolphe Thiébaut;Valentin Daucourt;Patrick Mercié;Didier K. Ekouévi

  • Changes in Cancer Mortality among HIV-Infected Patients: The Mortalité 2005 Survey

    Fabrice Bonnet;Christine Burty;Charlotte Lewden;Dominique Costagliola;Dominique Costagliola

  • Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline estimated glomerular filtration rate: a prospective international cohort study

    Amanda Mocroft;Jens D. Lundgren;Michael Ross;Christoph A. Fux

  • Cognitive disorders in HIV-infected patients: are they HIV-related?

    Fabrice Bonnet;Hélène Amieva;Fabienne Marquant;Charlotte Bernard

  • Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

    Jean-Michel Molina;Kathleen Squires;Paul E Sax;Pedro Cahn

  • Evaluation of cardiovascular risk factors in HIV-1 infected patients using carotid intima-media thickness measurement.

    Patrick Mercié;Rodolphe Thiébaut;Valérie Lavignolle;Jean-Luc Pellegrin

  • Once-Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus—Infected Patients

    Jean-Michel Molina;Françoise Ferchal;Corinne Rancinan;François Raffi

  • Treatment of Toxoplasmic Encephalitis in Patients with AIDS

    Brian Dannemann;J. Allen McCutchan;Dennis Israelski;Diane Antoniskis

Frequent Co-Authors

Fabrice Bonnet
Fabrice Bonnet University of Rennes
Geneviève Chêne
Geneviève Chêne University of Bordeaux
François Dabis
François Dabis University of Bordeaux
Dominique Salmon
Dominique Salmon Université Paris Cité
Rodolphe Thiébaut
Rodolphe Thiébaut University of Bordeaux
Isabelle Poizot-Martin
Isabelle Poizot-Martin Aix-Marseille University
Cécile Goujard
Cécile Goujard University of Paris-Saclay
Karine Lacombe
Karine Lacombe Hôpital Saint-Antoine
Jean-Michel Molina
Jean-Michel Molina Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to various allied fields, many of which offer flexible learning options through online programs. For those interested in advancing their medical knowledge alongside microbiology, several online medical programs provide accessible routes to medical-related careers without traditional campus constraints.

Public health is another complementary pathway, with numerous accredited online mph programs easy to get into designed to help students develop skills to manage community health effectively. These programs often emphasize epidemiology and disease prevention, closely aligning with microbiological studies.

For those drawn to supporting children in healthcare environments, becoming a certified child life specialist salary offers insight into both career expectations and financial prospects. This role merges emotional support with medical understanding, an excellent fit for microbiology graduates interested in patient care.

It's important to note that accessible education pathways are available for diverse backgrounds. Students with past challenges can find hope through the best degrees for felons, which include options in health and science fields. This opens doors for many to pursue fulfilling careers in microbiology and beyond.

Best Scientists Citing Philippe Morlat

Trending Scientists

Recently Published Articles